Skip to Content


In the US, Acitretin (acitretin systemic) is a member of the drug class antipsoriatics and is used to treat Pityriasis rubra pilaris, Psoriasis and Psoriatic Arthritis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories



Chemical Name

(all-E)-9-(4-metoxy-2,3,6-trimetylphenyl)-3,7-dimetyl-2,4,6,8-nonatetraenoic acid (WHO)

Foreign Names

  • Acitretinum (Latin)
  • Acitretin (German)
  • Acitrétine (French)
  • Acitretina (Spanish)

Generic Names

  • Acitretin (OS: BAN, USAN)
  • Acitrétine (OS: DCF)
  • Etretin (IS)
  • Ro 10-1670 (Roche) (IS)
  • Acitretin (PH: BP 2018, Ph. Eur. 9.5, USP 41)
  • Acitrétine (PH: Ph. Eur. 9)
  • Acitretinum (PH: Ph. Eur. 9.5)

Brand Names

  • Aceret
    Glenmark, India
  • Acetec
    Dr. Reddy's, India
  • Acicutan 10mg
    Dermapharm, Switzerland; Dermapharm, Germany
  • Acicutan 25mg
    Dermapharm, Switzerland; Dermapharm, Germany
  • Acitren
    Sun-Farm, Poland
  • Acitretin
    Morningside Healthcare, United Kingdom; Sabaa, Egypt
  • Acitretin 10 mg Genus
    Genus Pharmaceuticals, United Kingdom
  • Acitretin 25 mg Genus
    Genus Pharmaceuticals, United Kingdom
  • Acitretin Actavis
    Actavis Australia, Australia
  • Acitretin Orifarm
    Orifarm Generics, Sweden
  • Acitretina IFC
    Cantabria, Spain
  • Acitretine CF
    Centrafarm, Netherlands
  • Acitretine Genus Pharmaceuticals
    Genus, Malta
  • Acitretine IFC
    Industrial, Netherlands
  • Acitrexol
    AC Farma, Peru
  • Asset
    Pearl, Pakistan
  • Fang Xi
    Huabang Medical & Chemical, China
  • Keracutan 10 mg
    Pelpharma, Austria
  • Keracutan 25 mg
    Pelpharma, Austria
  • Keraderm
    Dermapharm, Netherlands
  • Neotigason
    2care4, Norway; Actavis, Czech Republic; Actavis, Denmark; Actavis, Algeria; Actavis, Egypt; Actavis, Hong Kong; Actavis, Iraq; Actavis, Lithuania; Actavis, Latvia; Actavis, Nigeria; Actavis, Norway; Actavis, New Zealand; Actavis, Sudan; Actavis, Sweden; Actavis, Singapore; Actavis, Slovakia; Actavis, Turkey; Actavis Baltics Eesti, Estonia; Actavis Group, Cyprus; Actavis Group, Greece; Actavis Group, Iceland; Actavis Group, Malta; Actavis Group, Poland; Actavis Group, Romania; Actavis Italy, Italy; Actavis UK, United Kingdom; Allergan, Thailand; Aurobindo, Belgium; Aurobindo, Netherlands; Aurovitas, Spain; BModesto, Netherlands; Cenexi SAS, Serbia; Dr. Fisher Farma, Netherlands; Euro Registratie, Netherlands; Generis, Portugal; Hoffmann La Roche, Kuwait; Pascual, Philippines; Patheon, Taiwan; Phoenix, Croatia (Hrvatska); Roche, Ecuador; Roche, Lithuania; Roche, Paraguay; Roche, Tunisia; Roche, Venezuela; Roche, South Africa; Roche Pharmaceutical, China; Sandoz, Argentina; Sandoz, Mexico; Solton, Peru; Teva, Australia
  • Neotigason 10 mg
    Actavis, Hungary
  • Neotigason 10mg
    Actavis, Israel; Aurobindo, Luxembourg; Cenexi, Bulgaria; Teva Pharma, Switzerland
  • Neotigason 25 mg
    Actavis, Hungary
  • Neotigason 25mg
    Actavis, Israel; Aurobindo, Luxembourg; Cenexi, Bulgaria; Teva Pharma, Switzerland
  • Novatin
    Apotex, Australia
  • Novatretin
    Douglas, New Zealand
  • Regioderm
    Regiomedica, Italy
  • Soriatane
    Actavis Specialty Pharmaceuticals, Canada; Arrow, France; Stiefel, United States
  • Unitrin
    Uni Pharma, Egypt
  • Zetin
    Arrow Pharmaceuticals, Australia


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.